黑料网

ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Infect Dis Ther,
  • DOI: 10.4172/2332-0877.1000499

Humoral Immune Response of Vaccinated Employees against SARS-CoV-2 in a Tertiary Hospital in Germany: CALM-UKA (COVID-19 Antibody Level Monitoring University Hospital Augsburg)

Johanna Maria Classen1*, Anna Muzalyova2, Christine Dhillon2,4, Elisabeth Kling3, Stephan Zellmer1, Ute Grossert5, Reinhard Hoffmann3, Renate Linne5, Michael Beyer5, Alanna Ebigbo1, Helmut Messmann1, Christoph Römmele1,2 and Elisabeth Schnoy1
1Department of Gastroenterology and Infectious Diseases, University Hospital Augsburg, Augsburg, Germany
2Department of COVID-19 Task Force, University Hospital Augsburg, Augsburg, Germany
3Laboratory of Medicine and Microbiology, University Hospital Augsburg, Augsburg, Germany
4Department of Pathology and Molecular Diagnostics, University Hospital Augsburg, Augsburg, Germany
5Department of Medicine, University Hospital Augsburg, Augsburg, Germany
*Corresponding Author : Dr. Johanna Maria Classen, Department of Gastroenterology and Infectious Diseases, University Hospital Augsburg, Augsburg, Germany, Email: johanna-maria.classen@uk-augsburg.de

Received Date: Apr 15, 2022 / Published Date: May 18, 2022

Abstract

Objectives: In the context of the SARS-CoV-2 pandemic, it is important to better understand whether and, more importantly, how long individuals who were administered a SARS-CoV-2 vaccination are protected from future infections. Healthcare workers are at permanent risk of exposure to SARS-CoV-2-safe and lasting vaccination response is therefore of immense importance. The aim of the present work is to record antibody titer against SARS-CoV-2 in a large cohort of vaccinated employees at the university hospital over time and to identify possible factors influencing antibody formation.

Methods: We retrospectively analyzed a cohort of 1045 employees who received vaccination against SARS-CoV-2 during the course with BNT162b2 vaccine from Biontech/Pfizer. Blood was drawn from the employees at predefined time points and analyzed for the presence of SARS-CoV-2 antibodies (IgG) against the Receptor Binding Domain (RBD) of the Spike protein (S). In addition, all participants completed a questionnaire.

Results: A total of 863 females (82.6%) and 182 males (17.4%) were screened. The mean antibody titer was 69127.8 BAU/ml (SD=69319.6 BAU/ml) in female participants and 60867.8 BAU/ml (SD=65249.6 BAU/ml) in male participants. There was no significant difference concerning gender and antibody levels (p=0.071). In a multivariate analysis, we found a significant influence of age on the antibody formation (p<0.001); the older the participants, the lower the antibody level. The highest antibody levels were detected in study participants 30-50 days after their first vaccination. 50 days after vaccination only lower antibody titer in proband could be detected.

Conclusion: In the large cohort of 1045 health care workers, a high heterogeneity of antibody titers was observed. There is a significant influence of age on antibody levels-older employees had a lower antibody titer. 50 days after vaccination only lower antibody titer in proband could be detected.

Keywords: Immune response; SARS-CoV-2; Antibodies; Vaccination

Citation: Classen JM, Muzalyova A, Dhillon C, Kling E, Zellmer S, et al. (2022) Humoral Immune Response of Vaccinated Employees against SARS-CoV-2 in a Tertiary Hospital in Germany: CALM-UKA (COVID-19 Antibody Level Monitoring University Hospital Augsburg). J Infect Dis Ther 10:499. Doi: 10.4172/2332-0877.1000499

Copyright: © 2022 Classen JM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top